Affordability and Value Archives - Families USA Skip to Main Content

Affordability and Value

Families USA Submits Testimony Supporting Illinois Bill to Address High Drug Costs

On April 14, 2026, Families USA submitted written testimony to the Illinois Health Care Availability and Accessibility Committee in support of HB1443/SB66. This proposed legislation would establish a ...

View More

Mind the Gap: Bridging the Oral Health Divide for More Affordable and Accessible Coverage

Our country’s affordability crisis is hurting everyday Americans’ access to health care and health coverage. That is just as true for oral health care as it is for other kinds of medical care. App...

View More

Consumers for Fair Hospital Pricing Statement for the Record for the Energy and Commerce Health Subcommittee Hearing on “Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider Landscape”

Ahead of the March 18 House Energy and Commerce Health Subcommittee hearing on "Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider Landscape," Consumers for Fair Hospita...

View More

Virginia Has the Opportunity to Lead on Lowering Prescription Drug Costs

The high cost of prescription drugs continues to strain families and state budgets alike. Now, Virginia has the opportunity to take a major step forward in lowering drug costs for families at the stat...

View More

Families USA Submits Testimony in Support of LD 2196 to Lower Health Insurance Costs and Reduce Barriers to Care

On March 5, 2026, Sophia Tripoli, senior director of health policy at Families USA, submitted written testimony to the Maine Joint Standing Committee on Health and Human Services, in support of LD 21...

View More

Families USA Submits Comment Letter on Proposed Transparency in Coverage (TiC) Rule

Families USA, on behalf of the Consumers First steering committee, submitted comments on the Centers for Medicare & Medicaid Services (CMS) proposed Transparency in Coverage (TiC) rule. Consumers...

View More

Families USA Comment on GUARD Drug Pricing Model

Families USA submitted comment on the Centers for Medicare & Medicaid Services (CMS) model GUARD (Guarding U.S. Medicare Against Rising Drug Costs). Families USA supports the broader efforts to...

View More
Statement or Comment

Families USA Submits Testimony Expressing Support for the Fair Pricing Act

On February 10th, 2026, Families USA submitted written testimony to the New York State Joint Legislative Budget Hearing on Health, expressing support for the Fair Pricing Act (S. 705/A. 2140). ...

View More

Families USA Statement for the Record for Energy and Commerce’s Health Subcommittee Hearing on Lowering Health Care Costs on Prescription Drugs

Families USA submitted a statement on the Energy and Commerce Health Subcommittee outlining how big drug companies and Pharmacy Benefit Managers (PBM) are driving up the cost of prescription drugs. ...

View More

Protect Medicare’s Future: Hold Medicare Advantage Insurance Companies Accountable for Rising Health Care Costs

The Medicare Advantage (MA) program — now covering more than 33 million older adults — was created to deliver higher-quality, more coordinated care at a lower cost. Yet unchecked corporate profite...

View More